StockpollyBeta
Get App
Delisting riskPopularity #3,720
VNRX · AMEX · Medical - Devices

VolitionRx (VNRX)

Builds blood-based diagnostics from nucleosome measurement and chromatin enrichment.

$0.2576
vs last close−0.01 (−2.76%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue00000001010
Cost of revenue00000000000
Gross profit00000001010
99766676565
Research & development45433332232
44433343333
Selling & marketing00000000011
General & administrative44333343332
Other expenses00000000000
Operating income−9−8−7−6−6−6−6−5−5−5−4
00000000−2−1−3
Interest income00000000000
Interest expense00000001111
Other non-operating income0000000−111−2
Income before tax−9−8−7−6−6−5−6−5−6−7−7
Net income from continuing operations−9−8−7−6−6−5−6−5−6−7−7
Net income−9−8−7−6−6−5−6−5−6−7−7
EPS, basic−$2.20−$2.00−$1.69−$1.32−$1.32−$1.12−$1.22−$1.00−$1.05−$0.97−$0.85
EPS, diluted−$2.20−$2.00−$1.69−$1.32−$1.32−$1.12−$1.22−$1.00−$1.05−$0.97−$0.85
Weighted average shares, basic44444555579
Weighted average shares, diluted44444555579
EBITDA−8−8−7−5−5−5−6−4−5−6−2
Depreciation & amortization00000000000
EBIT−9−8−7−6−6−5−6−5−5−6−2